Capitolis Liquid Global Markets’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$26.9M Sell
223,830
-236,570
-51% -$27.3M 0.17% 108
2025
Q4
$48.5M Buy
460,400
+206,700
+81% +$19.4M 0.29% 76
2025
Q3
$21.3M Sell
253,700
-415,000
-62% -$34.2M 0.17% 91
2025
Q2
$52.9M Buy
668,700
+65,000
+11% +$5.17M 0.39% 52
2025
Q1
$54.2M Hold
603,700
0.48% 46
2024
Q4
$60.1M Hold
603,700
0.58% 41
2024
Q3
$68.6M Buy
603,700
+302,000
+100% +$35.9M 0.73% 34
2024
Q2
$37.4M Buy
301,700
+215,000
+248% +$27.7M 0.46% 48
2024
Q1
$11.4M Buy
86,700
+13,400
+18% +$1.65M 0.18% 70
2023
Q4
$7.99M Buy
+73,300
New +$7.61M 0.33% 49

Other funds holding MRK

Capitolis Liquid Global Markets's MRK Position: Q1 2026 in Review

Capitolis Liquid Global Markets reduced its Merck (MRK) stake by 51% in Q1 2026, selling an estimated $27.3M and leaving 223,830 shares worth $26.9M. The position accounts for 0.17% of the portfolio, ranked #108.

Capitolis Liquid Global Markets first reported a position in MRK in Q4 2023 and has held it in 10 quarters since. The position peaked at $68.6M in Q3 2024. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Capitolis Liquid Global Markets held 223,830 shares of Merck worth $26.9M as of Q1 2026.
  • Capitolis Liquid Global Markets sold 236,570 Merck shares in Q1 2026, an estimated $27.3M.
  • Merck made up 0.17% of Capitolis Liquid Global Markets's portfolio in Q1 2026, its #108 holding.
  • Capitolis Liquid Global Markets first reported a position in Merck in Q4 2023 and has held it in 10 quarters since.
  • Capitolis Liquid Global Markets's Merck position peaked at $68.6M in Q3 2024.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Capitolis Liquid Global Markets's 13F filing for Q1 2026, filed 15 May 2026.